Translational Development Acquisition TDACU
NASDAQ TDACU
$11.48 +0.00 (+0.00%)
At close: Nov 5, 2026 · 4:00 PM EST

Translational Development Acquisition (TDACU) Non Operating Income (2024 - 2026)

Updated

Translational Development Acquisition (TDACU) posted Non Operating Income of $1.61 million for Q2 2026, down 12.8% from $1.84 million a year earlier and down 0.4% from the prior quarter.

Analysis

Translational Development Acquisition (TDACU) Non Operating Income (2024 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Non Operating Income at Translational Development Acquisition was $6.85 million, up 80.4% year-over-year; for FY2025, it came in at $7.31 million.

  • In prior years, Translational Development Acquisition's Non Operating Income was $125,346 in FY2024.
  • The Q2 2026 figure stands as the lowest quarterly Non Operating Income since Q4 2024.
  • According to Business Quant data, Non Operating Income for the three prior quarters was $1.61 million (Q1 2026), $1.76 million (Q4 2025) and $1.87 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.61 Mn
Mar 31, 2026 1.61 Mn
Dec 31, 2025 1.76 Mn
Sep 30, 2025 1.87 Mn
Jun 30, 2025 1.84 Mn
Mar 31, 2025 1.83 Mn
Dec 31, 2024 125,346.00
API Access

Translational Development Acquisition Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=TDACU&period=max&api_key=YOUR_API_KEY